An agricultural fungicide approved in the U.S. and currently under consideration by authorities worldwide could have a devastating effect on a new drug for one of world's deadliest infectious diseases, show University of ...
Cell & Microbiology
Jan 9, 2024
0
30
Today, medicines based on antibodies—proteins that fight infection and disease—are prescribed for everything from cancer to COVID-19 to high cholesterol. The antibody drugs are supplied by genetically-engineered cells ...
Biotechnology
Dec 12, 2023
0
74
One of the primary chlorine disinfectants currently being used to clean hospital scrubs and surfaces does not kill off the most common cause of antibiotic-associated sickness in health care settings globally, according to ...
Cell & Microbiology
Nov 21, 2023
1
207
Scientists have shown how a molecule with broad-spectrum antibiotic activity works by disabling a process vital to bacterial growth without affecting the normal functioning of human cells. The journal mBio published the work, ...
Cell & Microbiology
Nov 1, 2023
0
28
Since the discovery of penicillin in 1928, bacteria have evolved numerous ways to evade or outright ignore the effects of antibiotics. Thankfully, health care providers have an arsenal of infrequently used antibiotics that ...
Bio & Medicine
Oct 3, 2023
0
7
A team of researchers from the University of California, Irvine, have revealed the first crystal structures of the receptor-binding domain of botulinum neurotoxin E (BoNT/E) in complex with its human neuronal receptors, synaptic ...
Cell & Microbiology
Apr 27, 2023
0
367
National University of Singapore (NUS) pharmaceutical scientists have developed synthetic peptide nanonets for treating infections by bacteria strains resistant to last-resort antibiotics.
Bio & Medicine
Mar 6, 2023
0
82
Political ideology shapes attitudes about COVID-19 treatments not just for the general U.S. population but also for critical care physicians, according to new research led by University of Pittsburgh scientists.
Social Sciences
Feb 6, 2023
0
143
Scientists at Swansea University developing a platform that would use artificial intelligence to speed up the process of detecting biomarkers in biofluids have shown that the concept could work. It would mean faster test ...
Biochemistry
Oct 20, 2022
0
38
A compound that both inhibits the MRSA superbug and renders it more vulnerable to antibiotics has been discovered by scientists at the University of Bath led by Dr. Maisem Laabei and Dr. Ian Blagbrough.
Cell & Microbiology
Oct 11, 2022
0
438
